Hope for Patients Using NGS technology to identify targets.
Developing therapeutics that patients need.

Vision& Core Values

MedPacto is a genome-based drug discovery and
early clinical development company that is passionate about
creating innovative therapies for those dealing
with cancer and autoimmune diseases

  • Passion

    Transforming novel targets to innovative solutions
    for our patients

  • Scientific excellence

    Conducting ethically sound and transparent
    research & development

    Forming a strong team of industry experts

  • Mutual Collaboration

    Committed to improving the lives of patients

    Working together for shared benefits